WWG
ABBV icon

West Wealth Group’s AbbVie ABBV Stock Holding History

West Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534K Buy
2,120
+121
+6% +$26K 0.09% 83
2026
Q1 		$435K Hold
1,999
– – 0.09% 86
2025
Q4 		$457K Buy
1,999
+68
+4% +$15.5K 0.09% 74
2025
Q3 		$437K Buy
1,931
+108
+6% +$22K 0.1% 72
2025
Q2 		$358K Sell
1,823
-60
-3% -$11.2K 0.09% 74
2025
Q1 		$389K Buy
1,883
+38
+2% +$7.39K 0.11% 61
2024
Q4 		$328K Buy
1,845
+330
+22% +$60.7K 0.1% 66
2024
Q3 		$299K Buy
1,515
+9
+0.6% +$1.68K 0.1% 63
2024
Q2 		$258K Buy
1,506
+9
+0.6% +$1.49K 0.09% 70
2024
Q1 		$273K Buy
1,497
+9
+0.6% +$1.55K 0.1% 66
2023
Q4 		$231K Sell
1,488
-2
-0.1% -$292 0.09% 75
2023
Q3 		$222K Buy
+1,490
New +$219K 0.1% 66
2023
Q2 		– Sell
-1,557
Closed -$248K – 75
2023
Q1 		$248K Sell
1,557
-452
-22% -$69.1K 0.11% 53
2022
Q4 		$325K Buy
2,009
+22
+1% +$3.37K 0.16% 47
2022
Q3 		$266K Buy
1,987
+29
+1% +$4.16K 0.13% 49
2022
Q2 		$299K Buy
1,958
+13
+0.7% +$1.99K 0.14% 47
2022
Q1 		$315K Buy
1,945
+6
+0.3% +$872 0.13% 44
2021
Q4 		$262K Buy
+1,939
New +$229K 0.1% 46

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

West Wealth Group's ABBV Position: Q2 2026 in Review

West Wealth Group increased its AbbVie (ABBV) stake by 6.1% in Q2 2026, buying an estimated $26K and bringing the position to 2,120 shares worth $534K. The position accounts for 0.09% of the portfolio, ranked #83.

West Wealth Group first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • West Wealth Group held 2,120 shares of AbbVie worth $534K as of Q2 2026.
  • West Wealth Group bought 121 AbbVie shares in Q2 2026, an estimated $26K.
  • AbbVie made up 0.09% of West Wealth Group's portfolio in Q2 2026, its #83 holding.
  • West Wealth Group first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on West Wealth Group's 13F filing for Q2 2026, filed 6 Aug 2026.